Monthly Administration of a Continuous Erythropoietin Receptor Activator Provides Efficient Haemoglobin Control in Non-Dialysis Patients during Routine Clinical Practice: Results from the Non-Interventional, Single-Cohort, Multicentre, SUPRA Study

Author: Heidenreich Stefan  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.32, Iss.2, 2012-02, pp. : 99-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content